Equifax (EFX) Stock Forecast & Price Target

$239.90 -2.02 (-0.83%)

Closing price 03:59 PM Eastern

Extended Trading

$242.25 +2.35 (+0.98%)

As of 05:00 PM Eastern

Equifax - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 20 Analyst Ratings

Sell
0

Hold
7

Buy
13

Based on 20 Wall Street analysts who have issued ratings for Equifax in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 20 analysts, 7 have given a hold rating, 12 have given a buy rating, and 1 has given a strong buy rating for EFX.

Consensus Price Target

$285.00
18.80% Upside

According to the 20 analysts' twelve-month price targets for Equifax, the average price target is $285.00. The highest price target for EFX is $307.00, while the lowest price target for EFX is $240.00. The average price target represents a forecasted upside of 18.80% from the current price of $239.90.

Get the Latest News and Ratings for EFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Equifax and its competitors.

EFX Analyst Ratings Over Time

Type	Current Forecast 8/8/24 to 8/8/25	1 Month Ago 7/9/24 to 7/9/25	3 Months Ago 5/10/24 to 5/10/25	1 Year Ago 8/9/23 to 8/8/24
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	12 Buy rating(s)	13 Buy rating(s)	14 Buy rating(s)
Hold	7 Hold rating(s)	6 Hold rating(s)	5 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$285.00	$295.19	$292.00	$287.00
Forecasted Upside	18.80% Upside	11.08% Upside	8.22% Upside	2.32% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

EFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Equifax Stock vs. The Competition

Type	Equifax	Business Services Companies	S&P 500
Consensus Rating Score	2.70	2.72	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	18.80% Upside	422.40% Upside	13.84% Upside
News Sentiment Rating	Positive News See Recent EFX News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/23/2025	UBS Group 4 of 5 stars	Kevin McVeigh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$315.00 ➝ $278.00	+13.79%
7/23/2025	Citigroup 3 of 5 stars	Arthur Truslove Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$294.00 ➝ $290.00	+17.77%
7/23/2025	BMO Capital Markets 4 of 5 stars	Jeffrey Silber Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Market Perform ➝ Market Perform	$280.00 ➝ $260.00	+5.70%
7/23/2025	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Owen Lau Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$296.00 ➝ $279.00	+13.57%
7/23/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Steinerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$277.00 ➝ $272.00	+11.68%
7/23/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Haas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$310.00 ➝ $300.00	+23.53%
7/23/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Meuler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$310.00 ➝ $289.00	+20.86%
7/23/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Manav Patnaik Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$260.00 ➝ $240.00	+0.37%
6/23/2025	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Heather Balsky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$300.00 ➝ $285.00	+11.63%
6/20/2025	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$295.00	+16.37%
Get the Latest News and Ratings for EFX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Equifax and its competitors with MarketBeat's FREE daily newsletter.
6/18/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shlomo Rosenbaum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$277.00 ➝ $295.00	+15.31%
6/18/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Sabadra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$300.00	+17.51%
6/10/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Toni Kaplan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$295.00 ➝ $305.00	+11.76%
3/14/2025	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Grobler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$265.00	+11.75%
2/18/2025	Gordon Haskett Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Grom Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
2/11/2025	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Eade Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
2/7/2025	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform
1/15/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Surinder Thind Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$340.00 ➝ $300.00	+13.77%
12/12/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Wurtzel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Peer Perform
8/20/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$277.00 ➝ $307.00	+4.23%
2/13/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	In-Line ➝ Outperform	$210.00 ➝ $310.00	+21.21%
2/9/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$270.00 ➝ $285.00	+14.38%
1/11/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral	$272.00	+11.10%
12/8/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$218.00 ➝ $267.00	+19.05%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 06:30 PM ET.

Should I Buy Equifax Stock? EFX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, August 5, 2025. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

Equifax
Bull Case

Here are some ways that investors could benefit from investing in Equifax Inc.:

The current stock price is around $241, which reflects a strong performance in the market.
Equifax Inc. reported a quarterly earnings per share (EPS) of $2.00, exceeding analysts' expectations, indicating robust financial health.
The company has shown a revenue increase of 7.4% compared to the same quarter last year, suggesting growth potential.
With a return on equity of 18.89%, Equifax Inc. demonstrates effective management and profitability, which can attract investors.
The firm operates in three segments, providing diversified revenue streams that can mitigate risks associated with market fluctuations.

Equifax
Bear Case

Investors should be bearish about investing in Equifax Inc. for these reasons:

The company has a high price-to-earnings (P/E) ratio of 47.51, which may indicate that the stock is overvalued compared to its earnings.
Equifax Inc. has a debt-to-equity ratio of 0.79, suggesting a reliance on debt financing that could pose risks in a rising interest rate environment.
Insider selling activity has been noted, with significant shares sold by executives, which may raise concerns about their confidence in the company's future.
The current quick ratio of 0.77 indicates that the company may face challenges in meeting short-term liabilities, which could affect liquidity.
Market volatility, as indicated by a beta of 1.60, suggests that Equifax Inc.'s stock price may experience larger fluctuations compared to the overall market, increasing investment risk.

EFX Forecast - Frequently Asked Questions

: According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for Equifax is $285.00, with a high forecast of $307.00 and a low forecast of $240.00.
: 20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last year. There are currently 7 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" EFX shares.
: According to analysts, Equifax's stock has a predicted upside of 18.80% based on their 12-month stock forecasts.
: Over the previous 90 days, Equifax's stock had 1 downgrade by analysts.
: Equifax has been rated by research analysts at Bank of America, Barclays, BMO Capital Markets, Citigroup, JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Oppenheimer, Robert W. Baird, Royal Bank Of Canada, Stifel Nicolaus, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Equifax less than other "business services" companies. The consensus rating score for Equifax is 2.70 while the average consensus rating score for "business services" companies is 2.72. Learn more on how EFX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:EFX) was last updated on 8/8/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Equifax (EFX) Stock Forecast & Price Target